Vraylar
- Product NDC
- 61874-275
- 11-digit product format
- 618740275
- Labeler code
- 61874
- Product ID
- 61874-275_db2154b0-f0c7-403c-95fd-794666e79e30
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cariprazine
- Dosage form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Labeler
- Allergan, Inc.
- Application
- NDA204370
- Marketing category
- NDA
- Marketing start
- 2025-12-18
- Substance
- CARIPRAZINE
- Active strength
- .75 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| F6RJL8B278 | CARIPRAZINE | 839712-12-8 | CARIPRAZINE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 61874-275-30 | 61874027530 | 30 CAPSULE, GELATIN COATED in 1 BOTTLE (61874-275-30) | 2025-12-18 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Vraylar - Allergan, Inc. | Allergan, Inc. | 2025-12-18 | HUMAN PRESCRIPTION DRUG LABEL | 30 |